Approval · Notice of Compliance 19383 · 2017
FIBRYNA: Notice of Compliance 19383
Issued June 7, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19383
- Date
- June 7, 2017
- Company
- Octapharma Pharmazeutika Produktionsges M B HVienna, Vienne, Austria
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FIBRYNA | 02464616 | Marketed |
Medicinal ingredients
- FIBRINOGEN (HUMAN) 1 G per VIAL